Icon
+91 94997 68112
Login Register

Tracleer - (32 mg; Tablet for suspension, Oral)

Bosentan Actelion pharmaceuticals
32 mg; Tablet for suspension, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
Less Than 5
None None
Indications for Tracleer: -Pulmonary arterial hypertension (PAH) (WHO Group I) in adults with WHO Class II–IV symptoms to improve exercise ability and decrease clinical worsening
Yes
***** ** ***. ***** ***** * **** ** ** ****** '*** *** *** *********. ** ***** **** *** ***** **** ****** ** *** ****. *****, ******** ******* **** *****. ********* ** **********, ***** ***'* ****** **** ******* ***** ********** ** '*** ****** (*.* ***** *** **, ****). *****, ***** ****** ***** * **** ** ** ****** ******* (*** **, ****) *** *** *********. ** ****** **** **** ***** ****** ****** ** **** ****. *****, ******** ******* **** ***** ******. ********* ** **********, ***** ****** ***'* ****** ******* ****** ********** ** ****** '*** (*** **, ****).
Tracleer Patent 1 Patent 2
***** ******* *******
***** ****** ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ *** *** **, **** ******* ********* ******** ** *** **, ****
***** ****** ** \ ** **** *, **** ******* ********* ******** ***** *** **** ***
  1. *** **, **** : ***** ******** ******** *************** ***** **'* **** ** ****** **** ****** '*** (*** **, ****)
  2. *** **, **** : ******** *************** ***** * **** ******* ***** ** ****** '*** (*** **, ****)
  3. *** **, **** : ***** ****** ******** ******** *************** ***** **'* **** ** ****** **** ****** '*** (*** **, ****)
  4. *** **, **** : ******** ******* **** *****. ********* ** **********, ***** ***'* ****** **** ******* ***** ********** ** '*** ****** (*.* ***** *** **, ****)
  5. *** **, **** : ******** *************** ***** * **** ******* ***** ****** ** ****** '*** (*** **, ****)
  6. *** **, **** : ******** ******* **** ***** ******. ********* ** **********, ***** ****** ***'* ****** ******* ****** ********** ** ****** '*** (*** **, ****)

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.